Connecting you to content on EBSCOhost

Works matching AU Bedon, Luca

Results: 4

1

A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.

Published in:

Cells (2073-4409), 2021, v. 10, n. 3, p. 576, doi. 10.3390/cells10030576

By:

Polano, Maurizio;
Fabbiani, Emanuele;
Adreuzzi, Eva;
Cintio, Federica Di;
Bedon, Luca;
Gentilini, Davide;
Mongiat, Maurizio;
Ius, Tamara;
Arcicasa, Mauro;
Skrap, Miran;
Dal Bo, Michele;
Toffoli, Giuseppe;
Mattei, Fabrizio

Publication type:

Article

2

A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1075, doi. 10.3390/ijms22031075

By:

Bedon, Luca;
Dal Bo, Michele;
Mossenta, Monica;
Busato, Davide;
Toffoli, Giuseppe;
Polano, Maurizio

Publication type:

Article

3

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 652, doi. 10.1002/cpt.2960

By:

Polano, Maurizio;
Bedon, Luca;
Dal Bo, Michele;
Sorio, Roberto;
Bartoletti, Michele;
De Mattia, Elena;
Cecchin, Erika;
Pisano, Carmela;
Lorusso, Domenica;
Lissoni, Andrea Alberto;
De Censi, Andrea;
Cecere, Sabrina Chiara;
Scollo, Paolo;
Marchini, Sergio;
Arenare, Laura;
De Giorgi, Ugo;
Califano, Daniela;
Biagioli, Elena;
Chiodini, Paolo;
Perrone, Francesco

Publication type:

Article

4

Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical‐Biomolecular Markers Significantly Associated With Toxicity.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 686, doi. 10.1002/cpt.2511

By:

Bedon, Luca;
Cecchin, Erika;
Fabbiani, Emanuele;
Dal Bo, Michele;
Buonadonna, Angela;
Polano, Maurizio;
Toffoli, Giuseppe

Publication type:

Article